Methods and compositions for modulating immunity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 8, 2011
Grant Date -
Sep 17, 2009
app pub date -
May 22, 2009
filing date -
Nov 7, 1997
priority date (Note) -
Expired
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Patent Longevity
|
Forward Citations
|
Abstract
Methods and compositions for inducing immune suppression are disclosed. The methods involve administering an effective amount of a CD200 protein or a nucleic acid encoding a CD200 protein. The methods are useful in preventing graft rejection, fetal loss, autoimmune disease, and allergies. Methods and compositions for preventing immune suppression are also disclosed. The methods involve administering an effective amount of an agent that inhibits CD200. Such methods are useful in treating cancer.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
TRILLIUM THERAPEUTICS INC | 96 SKYWAY AVENUE TORONTO M9W 4Y9 |
International Classification(s)
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Clark, David A | Burlington, CA | 80 | 2074 |
# of filed Patents : 80 Total Citations : 2074 | |||
Gorczynski, Reginald M | Willowdale, CA | 23 | 302 |
# of filed Patents : 23 Total Citations : 302 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 8 Citation Count
- A61K Class
- 10.68 % this patent is cited more than
- 14 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
Date | Code | Event | Description |
---|---|---|---|
Apr 06, 2015 | STCH | INFORMATION ON STATUS: PATENT DISCONTINUATION | free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
Mar 08, 2015 | FP | LAPSED DUE TO FAILURE TO PAY MAINTENANCE FEE | Effective Date: Mar 08, 2015 |
Mar 08, 2015 | LAPS | LAPSE FOR FAILURE TO PAY MAINTENANCE FEES | |
Oct 17, 2014 | REMI | MAINTENANCE FEE REMINDER MAILED | |
Mar 08, 2011 | I | Issuance | |
Sep 17, 2009 | P | Published | |
May 22, 2009 | F | Filing | |
May 22, 2009 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GORCZYNSKI, REGINALD M.;CLARK, DAVID A.;REEL/FRAME:022725/0966;SIGNING DATES FROM 20040819 TO 20040923 Owner name: TRILLIUM THERAPEUTICS INC., CANADA free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GORCZYNSKI, REGINALD M.;CLARK, DAVID A.;SIGNING DATES FROM 20040819 TO 20040923;REEL/FRAME:022725/0966 Owner name: TRILLIUM THERAPEUTICS INC., CANADA |
Nov 07, 1997 | PD | Priority Date |

Matter Detail

Renewals Detail
